Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review

Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review

Waqar Waheed,1 Eric Newman,1 Marwa Aboukhatwa,2 Maryam Moin,3 Rup Tandan1 1Department of Neurological Sciences, The University of Vermont and the University of Vermont Medical Center, Burlington, VT, USA; 2Pharmacotherapy Department, University of Vermont Medical Center, Burlington, VT, USA; 3Depart...

Full description

Bibliographic Details
Main Authors: Waheed W, Newman E, Aboukhatwa M, Moin M, Tandan R
Format: Article
Language:English
Published: Dove Medical Press 2022-07-01
Series:Therapeutics and Clinical Risk Management
Subjects:
myasthenia gravis
pathophysiology
autoantibodies
complement
eculizumab
Online Access:https://www.dovepress.com/practical-management-for-use-of-eculizumab-in-the-treatment-of-severe--peer-reviewed-fulltext-article-TCRM

Internet

https://www.dovepress.com/practical-management-for-use-of-eculizumab-in-the-treatment-of-severe--peer-reviewed-fulltext-article-TCRM

Similar Items